SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-275108
Filing Date
2021-09-16
Accepted
2021-09-16 16:05:57
Documents
15
Period of Report
2021-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d195420d8k.htm   iXBRL 8-K 28194
2 EX-99.1 d195420dex991.htm EX-99.1 21603
3 EX-99.2 d195420dex992.htm EX-99.2 14082
7 GRAPHIC g195420g0916100845885.jpg GRAPHIC 2702
  Complete submission text file 0001193125-21-275108.txt   201079

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyme-20210916.xsd EX-101.SCH 2518
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20210916_lab.xml EX-101.LAB 17937
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20210916_pre.xml EX-101.PRE 11223
8 EXTRACTED XBRL INSTANCE DOCUMENT d195420d8k_htm.xml XML 3449
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 211258013
SIC: 2834 Pharmaceutical Preparations